Biosecure Act Excluded from Defense Bill, Boosting Chinese Biotech
TL;DR
A proposed biosecurity bill aimed at regulating Chinese biotech contractors, such as WuXi AppTec, was not included in the end-of-year defense package, which was considered its best opportunity for passage in the current session of Congress.
Topics:businesspolitics#biosecurity#chinese-biotech#congress#defense-legislation#politics#wuxi-apptec
- Biosecure bill is left out of end-of-year defense package, dealing blow to chances Endpoints News
- Biosecure Act Out of Key Defense Bill in Win for Chinese Biotech Bloomberg
- Biosecure Act MIA from US defense bill in key win for China biopharma service providers FiercePharma
- Biosecure Act left out of defense authorization bill Axios
- BIOSECURE Act, aimed at Chinese drug manufacturers, is dealt a major blow STAT
Want the full story? Read the original reporting
Read on Endpoints News